Background: Major blood loss during neurosurgery may result in a variety of complications, such as potentially fatal hemodynamic instability. Brain tumor and skull base surgery is among the high bleeding risk procedures. Tranexamic acid (TXA) has been found to reduce bleeding events in various fields of medicine.Methods: We searched for all randomized controlled trials published in English or Bahasa which compared the use of TXA with placebo in brain tumor surgery. The studies should include adult patients with intracranial tumor who received TXA before skin incision. The primary and secondary outcomes are intraoperative blood loss and the need of transfusion.Results: This meta-analysis included a total of 200 patients from three studies. TXA resulted in less blood loss with pooled mean difference of −292.80 (95% CI, −431.63, −153.96,P<0.05). The need of transfusion was not significant between TXA and control group (pooled mean difference −85.36, 95% CI, −213.23 – (42.51), P=0.19).Conclusion: TXA reduced the volume of blood loss but did not reduce the need of blood transfusion.
12 December 2025 in Surgical Neurology International
Background: Leptomeningeal metastasis (LM) is one of the complications of primary malignancies, particularly in solid tumors. The consequence of LM is increased intracranial pressure (ICP) or secondary hydrocephalus. The most frequent method for diverting cerebrospinal fluid (CSF) in this group is a ventriculoperitoneal shunt (VPS); however, the capability of CSF diversion in improving patients’ survival has been debatable. There is currently no established protocol for treating LM patients with elevated ICP. Methods: We searched for studies involving patients with LM who underwent CSF diversion in multiple search databases. The search flow followed the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocol criteria. Results: This review includes a total of 15 studies. The average age at diagnosis was 55.3 ± 3.9 years. Among 415 patients, lung cancer was the most frequent primary malignancy. Overall symptom improvement from CSF diversion is 86% (95% confidence interval [CI]: 0.79–0.92). Complication rate among patients who had permanent CSF diversion is 18% (95% CI: 0.11.24). Overall survival in the LM population can be improved by permanent CSF diversion ( P < 0.05). The superiority of the lumboperitoneal shunt over VPS in improving survival is yet to be determined due to a lack of statistically significant findings. Although the use of permanent CSF diversion in conjunction with reservoir devices is increasing, its superiority in improving survival has not yet been established. Conclusion: This review demonstrated that patients with LM may benefit from a higher chance of survival with permanent CSF diversion. Further research is required to determine the role of various CSF diversion methods in improving survival.
12 August 2022 in Surgical Neurology International
Background: Multiple primary malignancies (MPMs), especially coexistence of renal cell carcinoma (RCC) and glioblastoma multiforme (GBM), are rare. The most likely clinical diagnosis in patient with tumor in another organ is metastatic brain tumor. Although GBM is the most common brain tumor, it is rarely coexistent with other malignancies.Case Description: A 64-year-old female presented with headache and dizziness, along with abdominal pain for 2 weeks before being admitted. The abdominal computed tomography (CT) scan showed a kidney tumor. The patient developed left hemiplegia, and the brain CT scan showed an intracranial tumor. The patient suggested for radical nephrectomy and craniotomy tumor removal. Histopathology of the kidney and brain tumor revealed two different features, which showed RCC and GBM. Immunohistochemistry result confirmed the diagnosis of GBM and IDH1 wild type; coexistent with clear cell RCC.Conclusion: The coexistence of carcinoma and glioma should be regarded as coincidental cases if it did not accomplish the criteria for tumor-to-tumor metastasis or proven to be a genetic syndrome. This case report provides an addition to the literature about double primary malignancy in a single patient. More studies are needed to confirm whether they have causal relationship or merely coincidental findings.
30 September 2025 in Journal of Public Health Research and Community Health Development
Brain tumors were estimated to occur at 6.4 per 100,000 people each year. The incidence rate of brain tumors in children is reported to be 5.7% out of every 100,000 children, while in adults, the reported rate is significantly higher at 29.9% out of every 100,000 people. Banyuwangi Regency has an area of 5,782.50 km2 with a population in 2018 of 1,609,677 people with a density of around 278 people/km2. With such a large population, early detection of brain tumors is important for the public to understand. Early detection activity programs from community health centre need to be held with the hope that health workers will be able to provide education and information regarding early symptoms and signs of brain tumors as well as risk factors for brain tumors for prevention. Increasing public knowledge about alerting the early symptoms of brain tumors is one strategy that can be used to reduce death and disability rates due to brain tumors. The aim of this community service program is to increase the knowledge of the lay public and health workers regarding early detection and early treatment of brain tumors in Banyuwangi Regency. Pre- and post-test questionnaires were given before and after the material to evaluate the increase in knowledge about brain tumors for lay people and health workers in Banyuwangi Regency. The results obtained a significant increase (p < 0.01) between the pre-test and post-test scores so that this community service increases the knowledge of the community in Banyuwangi Regency.
Background: Tumors of the cerebellopontine angle (CPA) are challenging to resect and have been proven difficult for neurosurgeons to manage optimally. Superior petrosal vein complex (SPVC) as the main drainage system and close proximity to CPA could be an obstacle during operation. There is an incidence ranging from 55% to 84% of injury to one part of the SPVC during CPA tumor surgery.Case Description: We report a case of 65-year-old woman with CPA tumor, who complained of unilateral hearing loss, dizziness, and facial pain. During tumor resection, one part of SPV complex was injured, then cerebellar edema develops.Conclusion: This case provides an overview of surgical complication associated with venous sacrifice. This would support the agreement to preserve SPV regarding risks and improve the quality of surgical decision making.
5 October 2026 in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Background: Augmented Reality (AR) integrates virtual anatomical information into the real-world environment in real time and has emerged as a promising navigation adjunct in cranial neurosurgery. Compared with conventional neuronavigation (CN), AR Head-Mounted Display (HMD) systems project patient-specific anatomy directly into the surgeon’s field of view, potentially improving spatial perception, ergonomics, and surgical workflow. However, their clinical performance remains uncertain because the available evidence is limited and methodologically heterogeneous. This systematic review synthesizes the accuracy and efficiency of AR HMD in cranial neurosurgical procedures. Methods: A systematic review was conducted according to PRISMA guidelines. PubMed, Scopus, and ScienceDirect were searched for prospective clinical studies comparing AR HMD with conventional neuronavigation or reporting quantitative accuracy and/or efficiency outcomes in cranial neurosurgery. Results: Nine prospective non-randomized studies involving 186 patients were included. Accuracy was assessed using registration error, deviation error, percent overlap, and subjective or objective evaluations. Among the five studies reporting registration accuracy, registration error ranged from 1.86 to 4.4 mm. Deviation errors were approximately 4 mm, and spatial congruence exceeded 65%. Subjective and objective assessments also demonstrated favorable anatomical localization and lesion visualization. Efficiency outcomes included registration, setup, planning, and navigation time. Registration time ranged from 2.6 to 7.95 min. Among five comparative studies, two reported shorter procedural times with AR HMD, one reported comparable time, and two reported longer times than conventional neuronavigation. Conclusion: AR HMD technology is a promising adjunct for cranial neurosurgical navigation, providing clinically useful accuracy comparable to conventional neuronavigation in selected applications while improving spatial orientation, ergonomics, and surgical workflow. Current systems should be regarded as complementary rather than replacement technologies and appear most suitable for cranial procedures requiring low to moderate precision navigation. Further prospective multicenter studies with standardized validation protocols and continued technological refinement are needed before widespread clinical adoption.